Viewing data from:

CIPROFLOXACIN HYDROCHLORIDE

ANDA

CIPROFLOXACIN HYDROCHLORIDE | A076126 | CARLSBAD TECHNOLOGY INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: CIPRO(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.2655

per ea

Lowest NADAC/Unit

$0.0842

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
61442022450CIPROFLOXACIN HCL 750 MG TAB	$0.2655	EA	Generic	—	2026-06-17
61442022301CIPROFLOXACIN HCL 500 MG TAB	$0.1244	EA	Generic	—	2026-06-17
61442022305CIPROFLOXACIN HCL 500 MG TAB	$0.1244	EA	Generic	—	2026-06-17
61442022201CIPROFLOXACIN HCL 250 MG TAB	$0.0842	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 1 NDC (1 FSS)

Lowest Price

$29.01

Highest Price

$29.01

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51407-0165-01CIPROFLOXACIN HCL 500MG TAB	$29.01	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain11 active DMFs13 inactive

11 active API suppliers hold Drug Master Files for this ingredient.

BAYER AGCIPROFLOXACIN HYDROCHLORIDE

DMF 81341989

QUIMICA SINTETICA SACIPROFLOXACIN HYDROCHLORIDE

DMF 119661996

NEULAND LABORATORIES LTDCIPROFLOXACIN HYDROCHLORIDE USP

DMF 132501998

DR REDDYS LABORATORIES LTDCIPROFLOXACIN HYDROCHLORIDE, USP

DMF 138621998

HOLIDAY LABS MEXICO SA DE CVCIPROFLOXACIN HYDROCHLORIDE, USP

DMF 170612003

TARO PHARMACEUTICAL INDUSTRIES LTDCIPROFLOXACIN HYDROCHLORIDE, USP

DMF 179332004

ZHEJIANG HUAYI PHARMACEUTICAL CO LTDCIPROFLOXACIN HYDROCHLORIDE

DMF 180832004

AARTI DRUGS LTDCIPROFLOXACIN HYDROCHLORIDE

DMF 196112006

THINQ PHARMA-CRO LTDCIPROFLOXACIN HYDROCHLORIDE USP

DMF 306162016

TURTLE PHARMA PRIVATE LTDCIPROFLOXACIN HYDROCHLORIDE USP

DMF 332452018

PHLOW CORPCIPROFLOXACIN HYDROCHLORIDE USP

DMF 372062024

QUIMICA SINTETICA SAInactiveCIPROFLOXACIN HYDROCHLORIDE

DMF 85171990

CIPLA LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP IN BANGALORE, INDIA

DMF 86271990

UNION QUIMICO FARMACEUTICA SAInactiveCIPROFLOXACIN HYDROCHLORIDE

DMF 116021996

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 130721998

CIPLA LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 147092000

WOCKHARDT LTDInactiveCIPROFLOXACIN HYDROCHLORIDE, USP

DMF 149052000

MYLAN LABORATORIES LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 165442003

UNIQUE CHEMICALSInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 177862004

APITORIA PHARMA PRIVATE LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 185582005

ZHEJIANG XINHUA PHARMACEUTICAL CO LTDInactiveCIPROFLOXACIN HYDROCHLORIDE

DMF 198762006

ZHEJIANG JINGXIN PHARMACEUTICAL CO LTDInactiveCIPROFLOXACIN HYDROCHLORIDE

DMF 203372007

INDOCO REMEDIES LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 219092008

SMRUTHI ORGANICS LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 246362011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

2 letters from Drugs@FDA

Date	Submission	Document
Jun 16, 2026	SUPPL -15	View Letter (PDF)
Jun 15, 2004	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#002 — EQ 250MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 9, 2004

No patent or exclusivity listings for this strength.

#003 — EQ 500MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 9, 2004

#004 — EQ 750MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 9, 2004